Dermatological Therapeutics Market Size Worth $54.54 Billion by 2033 from $28.64 Billion in 2024 - SRI

AI Briefing

• – Dermatological therapeutics market expected to grow to $54.54 billion by 2033, up from $28.64 billion in 2024, driven by increasing prevalence of skin disorders and cosmetic concerns.
• – Key players in the market include Johnson & Johnson, Pfizer, and Merck & Co, with a focus on developing innovative treatments for skin conditions such as acne, psoriasis, and eczema.
• – Increasing demand for targeted therapies and rising investments in research and development are expected to drive market growth in the coming years.